Subscribe To

Price Alert Latest News Economic Calendar News

AMRS / AMYRIS PARTICIPATES IN INVESTOR CONFERENCES ON MAY 23, 24 AND 25, 2022

EMERYVILLE, Calif. , May 23, 2022 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab-to-Market™ technology platform, today announced that management is participating in fireside chats at the following investor conferences this week: Morgan Stanley Sustainable Futures Conference, Monday, May 23 at 2:00 PM ET (virtual) Cowen 6th Annual Future of the Consumer Conference, Tuesday, May 24 at 10:40 AM ET (in-person) UBS Global Healthcare Conference, Wednesday, May 25 at 11:30 AM ET (in-person) Live webcasts of the presentations and replays will be available on the Investor Relations section of the company's website at https://investors.amyris.com/events-and-presentations. Read More

Demo Live Account See Partner Details

Content Topics

Amyris

Participates

Investor

Conferences

2022

Stock

AMRS

Posted: May 23 2022, 17:36

Author Name: PRNewsWire

AMRS News

By Reuters
August 11, 2023

Retail investors flock to penny stocks WeWork, Amyris, Proterra

WeWork, a prized startup just four years ago but now a micro-cap, and other penny stocks such as Amyris and Proterra are the latest focus of speculati

By InvestorPlace
August 11, 2023

AMRS Stock Surges 152% as Amyris Files for Bankruptcy

Amyris (NASDAQ: AMRS ) stock is rising higher on Friday with heavy trading after the biotechnology company filed for bankruptcy. AMRS stock is bounci

By Investopedia
August 10, 2023

Biotech Company Amyris Files for Bankruptcy

Synthetic biotechnology company Amyris filed for Chapter 11 bankruptcy protection as it restructures, leading its share price to drop more than 70% in

By InvestorPlace
August 10, 2023

Why Is Amyris (AMRS) Stock Down 67% Today?

Amyris (NASDAQ: AMRS ) stock is falling on Thursday after the company filed for Chapter 11 bankruptcy protection. According to a press release from A

By Seeking Alpha
August 7, 2023

Amyris Warns Of Potential Bankruptcy - Sell

Cash-strapped specialty renewable products developer Amyris remains on life support by largest shareholder and creditor John Doerr. In recent months,

By The Motley Fool
July 11, 2023

Is It Time to Buy This Year's Worst-Performing Growth Stocks?

Not all low-priced stocks are appealing for investment, as some remain too unpredictable even at a lower buy-in price. This is a mixed bag and investo

By Seeking Alpha
July 3, 2023

Amyris: CEO's Exit Has Negative Implications

The resignation of Amyris' CEO is likely to be viewed as a positive by many, but the implications of this are negative. Management turnover and the en

By Seeking Alpha
June 27, 2023

Amyris: Company Separates From Long-Standing CEO Amid Ongoing Restructuring Efforts - Sell

Earlier this month, cash-strapped specialty renewable products developer Amyris announced a strategic transformation program to improve the company's

Risk Disclosure:

Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
We would like to remind you that the data contained in this website is not necessarily real-time nor accurate.
The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. We and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of us and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. We may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.